Event
Clinical Trials on Alzheimer's Disease
December 1 - December 4, 2025
San Diego, Calif.
The Clinical Trials on Alzheimer's Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and Academia getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.
This conference is expecting 2,200 key decision makers in the field of AD clinical trials; Industry leaders from major pharmaceutical companies involved in AD therapeutic trials; Internationally recognized researchers; KOL’s, etc.
Karla Kanis, M.D.
Therapeutic Area Lead, Neurology
Tuesday, Dec. 2
Poster 046
Submitter: Andreas Lysandropoulos, Franchise Head, Neurosciences, Ophthalmology, and Rare Diseases, Parexel
Presenter: Karla Kanis, Therapeutic Area Lead, Neurology, Parexel
Title: "Trends on patients’ recruitment and retention in Alzheimer’s disease modification trials"
Lydia Morris
Clinical Research Psychologist
Wednesday, Dec. 3
Poster P242
Submitter: Lydia Morris, Clinical Research Psychologist, California Clinical Trials Medical Group in affiliation with Parexel International, Lev Gertsik, Svetlana SEMENOVA
Presenter: Lydia Morris, Clinical Research Psychologist, California Clinical Trials Medical Group in affiliation with Parexel International
Title: “A novel approach for recruiting patients for early phase trials in Alzheimer’s Disease: Faster, simpler and with reduced patient burden.”
Request a meeting
Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.